MA55278A - Procédé de séchage à pulvérisation d'un peptide glp-1 - Google Patents

Procédé de séchage à pulvérisation d'un peptide glp-1

Info

Publication number
MA55278A
MA55278A MA055278A MA55278A MA55278A MA 55278 A MA55278 A MA 55278A MA 055278 A MA055278 A MA 055278A MA 55278 A MA55278 A MA 55278A MA 55278 A MA55278 A MA 55278A
Authority
MA
Morocco
Prior art keywords
glp
peptide
spray drying
spray
drying
Prior art date
Application number
MA055278A
Other languages
English (en)
Inventor
Marlene Hørslev Hansen
Ole Vangsgaard
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of MA55278A publication Critical patent/MA55278A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1688Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/26Glucagons
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/02Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by dividing the liquid material into drops, e.g. by spraying, and solidifying the drops
    • B01J2/04Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by dividing the liquid material into drops, e.g. by spraying, and solidifying the drops in a gaseous medium
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/605Glucagons

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Drying Of Solid Materials (AREA)
MA055278A 2019-03-15 2020-03-13 Procédé de séchage à pulvérisation d'un peptide glp-1 MA55278A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP19163103 2019-03-15

Publications (1)

Publication Number Publication Date
MA55278A true MA55278A (fr) 2022-01-19

Family

ID=65817893

Family Applications (1)

Application Number Title Priority Date Filing Date
MA055278A MA55278A (fr) 2019-03-15 2020-03-13 Procédé de séchage à pulvérisation d'un peptide glp-1

Country Status (9)

Country Link
US (1) US12138349B2 (fr)
EP (1) EP3938094B1 (fr)
JP (1) JP7549593B2 (fr)
CN (1) CN113631251B (fr)
IL (1) IL285391B2 (fr)
MA (1) MA55278A (fr)
MY (1) MY210034A (fr)
SG (1) SG11202108530VA (fr)
WO (1) WO2020187712A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114146163B (zh) * 2021-12-07 2023-09-26 苏州天马医药集团天吉生物制药有限公司 司美格鲁肽制剂的制备方法
WO2025133729A1 (fr) 2023-12-18 2025-06-26 Assia Chemical Industries Ltd. Procédé de préparation de peptides glp-1 et de peptides glp-1/gip doubles ayant une taille de particule contrôlée

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1167427A (ja) 1997-08-27 1999-03-09 Bridgestone Corp ヒーター部品
US6560897B2 (en) 1999-05-03 2003-05-13 Acusphere, Inc. Spray drying apparatus and methods of use
AU2001264789A1 (en) 2000-06-08 2001-12-17 Eli Lilly And Company Protein powder for pulmonary delivery
FI121528B (fi) 2000-10-30 2010-12-31 Biohit Oyj Farmaseuttinen koostumus syöpään sairastumisen riskin vähentämiseen paikallisesti sitomalla asetaldehydi syljessä, mahalaukussa tai paksusuolessa
AU2002308706A1 (en) 2001-06-01 2002-12-16 Eli Lilly And Company Glp-1 formulations with protracted time action
US7683029B2 (en) * 2003-05-07 2010-03-23 Philip Morris Usa Inc. Liquid aerosol formulations containing insulin and aerosol generating devices and methods for generating aerosolized insulin
CL2004001884A1 (es) * 2003-08-04 2005-06-03 Pfizer Prod Inc Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros.
TWI362392B (en) 2005-03-18 2012-04-21 Novo Nordisk As Acylated glp-1 compounds
WO2007084460A2 (fr) * 2006-01-18 2007-07-26 Qps, Llc Compositions pharmaceutiques a stabilite amelioree
EP2010754A4 (fr) 2006-04-21 2016-02-24 Shell Int Research Ajustement de compositions d'alliages pour obtenir des proprietes choisies dans des systemes de chauffage a temperature limitee
EP2158029B1 (fr) * 2007-04-10 2019-05-29 Gea Process Engineering Inc. Filtre pour gaz de procédé et procédé de nettoyage pour le filtre
WO2008133908A2 (fr) 2007-04-23 2008-11-06 Intarcia Therapeutics, Inc. Formulations en suspension de peptides insulinotropes et leurs utilisations
JP5496082B2 (ja) * 2007-04-30 2014-05-21 ノボ・ノルデイスク・エー/エス タンパク質組成物を乾燥させる方法、乾燥タンパク質組成物、及び乾燥タンパク質を含有する薬学的組成物
CA2711984A1 (fr) 2008-01-15 2009-07-23 Abbott Gmbh & Co. Kg Composition de proteine pulverisee et procedes de fabrication de celle-ci
CN101244111A (zh) * 2008-03-26 2008-08-20 巫军 红景天苷的制备及其在医药领域中的应用
CN102281865B (zh) 2008-10-15 2017-04-05 精达制药公司 高浓缩药物颗粒、制剂、混悬剂及其应用
EP2370059A1 (fr) * 2008-11-28 2011-10-05 Novo Nordisk A/S Compositions pharmaceutiques appropriées pour une administration orale de dérivé de peptide d'insuline
US20100183876A1 (en) * 2008-12-23 2010-07-22 Hell Andre Process for the Preparation of a Peptide Powder Form
CN201926251U (zh) 2010-09-26 2011-08-10 常州力马干燥工程有限公司 闭路循环喷雾干燥及溶媒回收装置
CN101949635B (zh) 2010-09-26 2012-02-22 常州力马干燥工程有限公司 闭路循环喷雾干燥及溶媒回收系统
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
HRP20181447T1 (hr) * 2012-03-22 2018-11-02 Novo Nordisk A/S Pripravci glp-1 peptida i njihova priprava
KR20150126382A (ko) 2013-03-12 2015-11-11 바이오히트 오와이제이 위 내의 알데하이드에 결합하는 캡슐화된 조성물
US20160206562A1 (en) 2013-08-21 2016-07-21 Nrl Pharma, Inc. Method for producing microparticles
GR20140100479A (el) * 2014-09-23 2016-05-05 Novetide, Ltd., Συνθεση λιραγλουτιδης
CN105340883B (zh) * 2015-11-26 2018-01-30 贵州大学 一种黑曲霉微丸
CN106166396B (zh) 2016-07-12 2018-04-13 常州三全干燥设备有限公司 一种节能型闭路循环喷雾干燥系统
WO2018069777A1 (fr) * 2016-10-13 2018-04-19 Capsugel Belgium Nv Procédé de fabrication de compositions séchées par pulvérisation et appareil de séchage par pulvérisation
CN108653234B (zh) * 2017-04-01 2021-02-26 中国科学院上海药物研究所 载有多肽蛋白类药物的固体颗粒物及包含该颗粒物的双肠溶固体制剂、其制备方法及用途
KR102665710B1 (ko) 2017-08-24 2024-05-14 노보 노르디스크 에이/에스 Glp-1 조성물 및 그 용도
CN207412769U (zh) * 2017-10-26 2018-05-29 吉安市御美丽健康产业股份有限公司 一种药品生产用喷雾干燥机
CN208287512U (zh) 2018-03-28 2018-12-28 江苏红瑞制药有限公司 一种血塞通分散片制备用闭式循环喷雾干燥系统
ES2994462T3 (en) 2018-12-21 2025-01-24 Novo Nordisk As Process of spray drying of glp-1 peptide

Also Published As

Publication number Publication date
IL285391B1 (en) 2023-01-01
CN113631251A (zh) 2021-11-09
EP3938094A1 (fr) 2022-01-19
JP2022525019A (ja) 2022-05-11
WO2020187712A1 (fr) 2020-09-24
EP3938094B1 (fr) 2026-05-06
US20220370362A1 (en) 2022-11-24
US12138349B2 (en) 2024-11-12
IL285391B2 (en) 2023-05-01
BR112021016694A2 (pt) 2021-10-13
IL285391A (en) 2021-09-30
SG11202108530VA (en) 2021-09-29
MY210034A (en) 2025-08-22
JP7549593B2 (ja) 2024-09-11
CN113631251B (zh) 2025-04-25

Similar Documents

Publication Publication Date Title
EP3600188C0 (fr) Procédé de fabrication d'un pansement
MA54862A (fr) Procédé de préparation d'un agoniste double gip/glp1
EP3977055C0 (fr) Procédé de détermination d'un itinéraire
EP4083051A4 (fr) Procédé de synthèse d'un composé peptidique
MA54510A (fr) Procédé de séchage par pulvérisation de peptide glp-1
MA53378A (fr) Procédé d'utilisation d'un co-agoniste de gip/glp1 contre le diabète
EP3846343A4 (fr) Substrat composite et procédé de fabrication d'un substrat composite
EP3852631A4 (fr) Procédé d'imagerie
EP3841488A4 (fr) Procédé d'interrogation d'un long discours
EP3603919A4 (fr) Procédé de récupération d'éléments constitutifs à partir d'un article absorbant usagé
EP3722878A4 (fr) Procédé d'exposition à balayage rapide basé sur un dmd
MA55278A (fr) Procédé de séchage à pulvérisation d'un peptide glp-1
CL2020001311S1 (es) Un cabezal de pulverizador portátil
EP3862404A4 (fr) Procédé de fabrication d'un objet lié et objet lié
EP4036131A4 (fr) Procédé d'enregistrement d'image
EP3917577A4 (fr) Variantes d'hormone parathyroïdienne
EP3919374A4 (fr) Procédé de capture d'image
EP3578383C0 (fr) Procédé de finissage d'un panneau de construction
EP3990815C0 (fr) Bouchon de serrage et procédé de serrage d'un tuyau associé
EP3960178A4 (fr) Procédé de traitement de la douleur associée à l'endométriose à l'aide d'un composé de diaminopyrimidine
EP3748066A4 (fr) Procédé de fabrication d'agrafe sertie de protéine
EP3808580A4 (fr) Stabilisateur et procédé de fabrication d'un tel stabilisateur
EP3804978A4 (fr) Élément composite recouvert et procédé de fabrication d'un élément composite recouvert
EP3398695A4 (fr) Nettoyeur haute pression et procédé d'identification d'une rampe de pulvérisation correspondante
EP3887092A4 (fr) Procédé de revêtement par saupoudrage à sec d'un plancher en béton